Products > Supplier info centre
Vetter Pharma International GmbH
Vetter Pharma International GmbH
Established: 1953
Number of staff: 2,700
Key Personnel: Max Horn, managing director; Thomas Otto, managing director; Peter Soelkner, managing director
Who we are:
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with a broad array of compounds, including monoclonal antibodies, peptides, interferons and vaccines. Combining state-of-the-art technology with innovative processes, Vetter can preserve API and helps reduce time-to-market. The firm supports clients from preclinical development through global market supply. Vetter works with the world´s leading pharmaceutical and biotech companies and offers a more than 25-year history of quality, innovation and strategic partnership. The new Chicago facility, an expansion of Vetter Development Service, provides early-stage product support.
Major Markets: Europe, North America and Japan
Services Offered:
Vetter Development Service includes:
- Primary Packaging Development
- Process Development
- Clinical Manufacturing
- Pharmaceutical Analysis
- Regulatory Affairs Services
- Transfer to Vetter Commercial Manufacturing
Vetter Commercial Manufacturing includes:
- Fill and finish
- Packaging Service
- Pharmaceutical Analysis
- Regulatory Affairs Services
Vetter Solutions include:
- Dual-chamber technology, e. g. suitable for lyophilized, liquid and powdered substances:
- lyophilisate/solvent
- liquid/liquid
- powder/liquid
- Anti-Counterfeiting Solutions
Dosage forms: Syringes, cartridges, vials